Total Payments
$1,259
2024 Payments
$759.72
Companies
10
Transactions
23
Medicare Patients
940
Medicare Billing
$130,836
Payment Breakdown by Category
Food & Beverage$1,259 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,259 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $339.44 | 4 | $0 (2024) |
| Medtronic, Inc. | $169.44 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $159.25 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $124.02 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $121.40 | 1 | $0 (2023) |
| GENZYME CORPORATION | $104.47 | 1 | $0 (2023) |
| Boston Scientific Corporation | $88.98 | 4 | $0 (2024) |
| Madrigal Pharmaceuticals | $78.54 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $53.71 | 1 | $0 (2023) |
| Ardelyx, Inc. | $20.10 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $759.72 | 14 | ABBVIE INC. ($339.44) |
| 2023 | $485.69 | 8 | E.R. Squibb & Sons, L.L.C. ($121.40) |
| 2022 | $13.94 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($13.94) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $106.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $124.02 | General |
| Category: INFLAM | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $78.54 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Medtronic, Inc. | MANOSCAN (Device) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: Motility Testing | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Medtronic, Inc. | BRAVO (Device) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Reflux Testing | ||||||
| 08/21/2024 | Medtronic, Inc. | MANOSCAN (Device) | Food and Beverage | In-kind items and services | $36.76 | General |
| Category: Motility Testing | ||||||
| 08/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.36 | General |
| Category: IMMUNOLOGY | ||||||
| 04/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: General - Therapies_ENDO | ||||||
| 02/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $87.75 | General |
| Category: IMMUNOLOGY | ||||||
| 01/31/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/12/2024 | Medtronic, Inc. | HET (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Electrosurgical Products | ||||||
| 11/08/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $53.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: General - Therapies_ENDO | ||||||
| 09/28/2023 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $121.40 | General |
| Category: Neuroscience | ||||||
| 09/21/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $104.47 | General |
| Category: Immunology | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $110.88 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/30/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: General - Therapies_ENDO | ||||||
| 08/16/2023 | Medtronic, Inc. | DIGITRAPPER (Device) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Reflux Testing | ||||||
| 08/07/2023 | Medtronic, Inc. | MANOSCAN (Device) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Motility Testing | ||||||
| 12/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 104 | 143 | $39,790 | $11,243 |
| 2022 | 7 | 281 | 498 | $150,102 | $42,975 |
| 2021 | 6 | 249 | 486 | $148,757 | $37,003 |
| 2020 | 8 | 306 | 453 | $157,351 | $39,614 |
Total Patients
940
Total Services
1,580
Medicare Billing
$130,836
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 65 | $24,310 | $6,424 | 26.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 63 | $11,655 | $3,713 | 31.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $3,825 | $1,107 | 28.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 65 | 156 | $41,264 | $12,256 | 29.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 176 | $33,253 | $9,619 | 28.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 49 | 49 | $30,419 | $7,208 | 23.7% |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | Office | 2022 | 15 | 15 | $13,185 | $4,874 | 37.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 55 | 55 | $14,445 | $4,391 | 30.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 33 | $13,014 | $3,334 | 25.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,522 | $1,292 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 50 | 147 | $45,701 | $11,684 | 25.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 205 | $45,686 | $11,320 | 24.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 48 | 48 | $21,282 | $5,023 | 23.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 32 | $20,336 | $4,849 | 23.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 43 | 43 | $13,369 | $3,508 | 26.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 11 | 11 | $2,383 | $619.41 | 26.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 64 | 151 | $49,579 | $12,304 | 24.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 56 | 56 | $33,560 | $8,769 | 26.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 52 | 112 | $26,798 | $6,452 | 24.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 45 | 45 | $14,315 | $3,820 | 26.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 31 | 31 | $15,159 | $3,304 | 21.8% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 28 | 28 | $9,024 | $2,828 | 31.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 17 | 17 | $6,160 | $1,381 | 22.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 13 | 13 | $2,756 | $755.56 | 27.4% |
About Pranav Patel
Pranav Patel is a Hospitalist healthcare provider based in Danville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2014. The National Provider Identifier (NPI) number assigned to this provider is 1548689987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Pranav Patel has received a total of $1,259 in payments from pharmaceutical and medical device companies, with $759.72 received in 2024. These payments were reported across 23 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,259).
As a Medicare-enrolled provider, Patel has provided services to 940 Medicare beneficiaries, totaling 1,580 services with total Medicare billing of $130,836. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Danville, PA
- Active Since 04/14/2014
- Last Updated 10/06/2023
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1548689987
Products in Payments
- RINVOQ (Biological) $219.08
- Livdelzi (Drug) $124.02
- ZEPOSIA (Drug) $121.40
- SKYRIZI (Biological) $120.36
- GATTEX (Drug) $110.88
- DUPIXENT (Biological) $104.47
- MANOSCAN (Device) $97.70
- REZDIFFRA (Drug) $78.54
- REBYOTA (Biological) $53.71
- EOHILIA (Drug) $34.43
- BRAVO (Device) $29.30
- DIGITRAPPER (Device) $24.23
- IBSRELA (Drug) $20.10
- HET (Device) $18.21
- ENTYVIO (Biological) $13.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Danville
Olumide Ajayeoba, Md, MD
Hospitalist — Payments: $2,943
Hospitalist $2,943
Dr. Raja Irfan Sadiq, M,D, M,D
Hospitalist — Payments: $2,797
Hospitalist $2,797
Kristen Salava
Hospitalist — Payments: $1,716
Hospitalist $1,716
Adam Kichler, D.o, D.O
Hospitalist — Payments: $947.95
Hospitalist $947.95
Dr. Arupreet Kochar, Md, MD
Hospitalist — Payments: $895.84
Hospitalist $895.84
Dr. Jenny So
Hospitalist — Payments: $533.39
Hospitalist $533.39